Who we are

Meet our team.

We have assembled a team of experienced scientists and industry pioneers, including cancer and diagnostic experts and accomplished company builders who are passionate about changing the outlook of a cancer diagnosis.

Our investors include Third Rock Ventures, Section 32, Casdin Capital, Biomatics Capital, BlueCross BlueShield Venture Partners, Invus and others – leading investors in the fields of cancer diagnosis and treatment.

David J. Daly Chief Executive Officer View Bio ›
Christoph Lengauer, Ph.D. Co-Founder and Chief Innovation Officer; Partner, Third Rock Ventures View Bio ›
Isaac Ro Chief Financial Officer View Bio ›
Dina Ciarimboli Chief Legal Officer View Bio ›
Matt Franklin Chief Commercial Officer View Bio ›
Semi Trotto Chief People Officer View Bio ›
Sam Asgarian, M.D. Chief Medical Officer View Bio ›
Seema Singh Bhan SVP, Public Policy and External Affairs View Bio ›
Geoff Otto, Ph.D. SVP & Head of Product Development View Bio ›
Isaac Kinde, M.D., Ph.D. Co-Founder, Head of Research and Innovation View Bio ›
Frank Diehl, Ph.D. EVP, Product Solutions View Bio ›
Kenneth W. Kinzler, Ph.D. Professor of Oncology, Co-Director of the Ludwig Institute at the Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University View Bio ›
Nickolas Papadopoulos, Ph.D. Professor of Oncology and Pathology at the Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University View Bio ›
Bert Vogelstein, M.D. Clayton Professor of Oncology and Pathology and Co-Director of the Ludwig Institute at the Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University; Investigator, Howard Hughes Medical Institute View Bio ›
Steven J. Kafka, Ph.D. Chairman; Managing Partner, Section 32 View Bio ›
Alexis Borisy Life Sciences Entrepreneur and Investor View Bio ›
Eli Casdin Founder and Chief Investment Officer, Casdin Capital View Bio ›
David J. Daly Chief Executive Officer View Bio ›
Neil Exter Partner, Third Rock Ventures View Bio ›
Christoph Lengauer, Ph.D. Co-Founder and Chief Innovation Officer; Partner, Third Rock Ventures View Bio ›
Nickolas Papadopoulos, Ph.D. Professor of Oncology and Pathology at the Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University View Bio ›
Michael Pellini, M.D. Managing Partner, Section 32 View Bio ›
Learn More

About our work.

What We Do